Trial Profile
Effect of Pitavastatin and EPA on coronary artery calcification detected by computed tomography.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Sep 2017
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary) ; Eicosapentaenoic acid
- Indications Atherosclerosis; Coronary artery disease; Dyslipidaemias
- Focus Therapeutic Use
- Acronyms PEACH
- 01 Sep 2017 Primary endpoint (CAC volume) has not been met as per the results published in the Circulation Journal
- 01 Sep 2017 Primary endpoint (The effect of Pitavastatin on coronary calcification score.) has not been met as per the results published in the Circulation Journal
- 01 Sep 2017 Results published in the Circulation Journal